These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6106457

  • 1. Altered pharmacokinetics of beta-adrenoceptor blocking drugs in patients with renal insufficiency.
    Tjandramaga TB.
    Arch Int Pharmacodyn Ther; 1980; Suppl():38-53. PubMed ID: 6106457
    [Abstract] [Full Text] [Related]

  • 2. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP, Dayer P, Fabre J.
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [Abstract] [Full Text] [Related]

  • 3. Geriatric clinical pharmacology.
    Rocci ML, Vlasses PH, Abrams WB.
    Cardiol Clin; 1986 May; 4(2):213-25. PubMed ID: 2871935
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B.
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP, Houin G, Ledudal P, Cautreels W, Giudicelli CP, Tillement JP.
    Int J Clin Pharmacol Res; 1984 Jun; 4(3):165-73. PubMed ID: 6149194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Disease-induced modifications of drug pharmacokinetics.
    Barre J, Houin G, Brunner F, Bree F, Tillement JP.
    Int J Clin Pharmacol Res; 1983 Jun; 3(4):215-26. PubMed ID: 6381335
    [Abstract] [Full Text] [Related]

  • 12. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L, Gorgia A, Marmy A, Tschopp JM.
    Nephrologie; 1980 Jun; 1(4):177-82. PubMed ID: 6895408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Correlation between pharmacological response, kinetics of plasma concentration and in vitro receptor affinities exemplified with beta-adrenoceptor blocking drugs.
    Wellstein A, Palm D.
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):641-4. PubMed ID: 6151037
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Drug therapy in renal failure.
    Muther RS, Bennett WM.
    Compr Ther; 1982 May; 8(5):44-57. PubMed ID: 7094560
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
    Borchard U.
    Clin Physiol Biochem; 1990 May; 8 Suppl 2():28-34. PubMed ID: 1982759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.